The current valuation score of Tarsus Pharmaceuticals Inc is 9.65, ranking 10 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -56.73, which is -94.05% below the recent high of -3.38 and -3.20% above the recent low of -58.55.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.